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Consensus techniques, such as the nominal 
group technique (NGT) or Delphi technique, are 
commonly used with health professionals for 
developing clinical practice and setting priori-
ties (Jones and Hunter, 1995). The aim of con-
sensus methods is to determine the degree to 
which experts agree about a particular issue 
(Jones and Hunter, 1995). The use of such meth-
ods is valuable where unanimity of opinion does 
not exist because of lack of scientific evidence 
or the complexity of the issue. The NGT and the 
Delphi technique use multiple rounds of ranking 
to achieve consensus. However, the NGT is 
conducted through face-to-face meetings to 
facilitate discussion and consensus-forming, 
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whereas the Delphi technique traditionally uses 
repeated postal or on-line questionnaires with 
summaries of individual and group ranking 
from previous rounds. Their systematic and 
democratic process equalizes decision making 
among participants and allows individual opin-
ions to be informed by the community of experts 
(Ginsburg et al., 1997).
These consensus techniques have also been 
used with patients as experts of living with the 
condition, both in mixed groups with health 
professionals and patient-only groups. In rela-
tion to priority setting, the NGT has been used 
with people with a range of physical and mental 
health conditions, including chest pain (Fleck 
et al., 2001), chronic pain (Dewar et al., 2003) 
and with intellectual disabilities (Tuffrey-Wijne 
et al., 2007) to determine care preferences and 
priorities. The Delphi technique has been used 
with people with conditions such as multiple 
sclerosis (O’Hara et al., 2000), and juvenile idi-
opathic arthritis (Shaw et al., 2004). It is widely 
recognized that patients can reliably and validly 
express views on many dimensions of care and 
outcomes, although they may not be able to 
evaluate all aspects of the technical side of 
their care (Hewlett et al., 2006). Patients have a 
‘personal experience of disease that is not avail-
able to most researchers, which complements 
researchers’ analytical skills and scientific per-
spective’ (Hewlett et al., 2006: 678). Policy 
states that patients should have more say in deci-
sions affecting their care (Department of Health, 
2000) and that patient perspective should be 
incorporated into clinical drug trials (Food and 
Drug Administration, 2009), although user 
involvement is often challenging (Craig, 2008).
RA is a chronic inflammatory autoimmune 
disease, mainly affecting the peripheral joints, 
causing swollen, painful joints, and character-
ized by fluctuating inflammatory activity 
(Arnett et al., 1988). It is two to three times 
more prevalent among women and peak inci-
dence is between 30 and 50 years of age 
(Lawrence et al., 1989). There is evidence 
that the assessment and valuation of out-
comes for treatment of RA differ between 
health professionals and patients (Hewlett, 
2003). Although measurement of disease activ-
ity in RA clinical trials has been standardized 
by the development of ‘core sets’ of variables 
constructed by professional experts in rheuma-
tology (Felson et al., 1993), the use of patient-
reported outcomes (PROs) is not standardized 
and outcomes known to be important to patients, 
such as fatigue and coping, are commonly not 
assessed (Kalyoncu et al., 2009). This nominal 
group study was part of a larger research agenda 
to develop a set of patient priority treatment 
outcomes for pharmacological interventions in 
RA (Sanderson et al., 2010a, 2010b). This arti-
cle focuses on the qualitative findings, and 
reflects on the benefits and challenges of cap-
turing qualitative data in nominal groups.
Methods
The NGT was used with patients diagnosed 
with RA according to American College of 
Rheumatology (ACR) criteria (Arnett et al., 
1988), to rate the importance of and prioritize 
63 outcomes generated by patients in a previ-
ous interview study (Sanderson et al., 2010a). 
Participants were identified from an outpatient 
rheumatology unit, from both the anti-TNF 
(Tumour Necrosis Factor) therapy database 
(medications used for severe disease and where 
other drugs have failed), and clinical notes. 
Participants were purposively sampled for self-
reported disease activity (Disease Activity 
Score (DAS) patient opinion scale), disease 
duration, medication, gender, age and work 
status. Purposive sampling is appropriate for 
consensus techniques where experience and 
knowledge of an issue in paramount (Keeney 
et al., 2005). Single and mixed gender groups 
were trialled to see whether this would affect 
the treatment outcomes being prioritized. Two 
(of the five) groups were formed only of people 
with experience of anti-TNF therapy, while the 
remaining three groups were formed with peo-
ple on other types of medications. A patient was 
part of the steering group to ensure user collab-
oration in the research design. In our research 
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unit, the term ‘patient research partner’ is used, 
reflecting that the person is both a patient, and 
a partner in the research process (Hewlett et 
al., 2006). Ethics approval was granted by a 
Multicentre Research Ethics Committee (MREC) 
(ref. 07/H1107/138), and consent was taken 
before participation.
In each group that was held, three rounds of 
the NGT took place to facilitate the prioritiza-
tion process. These rounds are reported in detail 
to provide a replicable method.
Round 1: Individual rating of 
personal importance of outcomes
The treatment outcomes were generated by 
other RA patients in a previous interview study 
(Sanderson et al., 2010a), and used participants’ 
own words. Each outcome was printed on a 
separate laminated card to aid ranking, with a 
set provided for each participant. Each set was 
shuffled to ensure that the results were not 
biased by a particular ordering. Participants 
were given a sorting sheet with the instruc-
tion: ‘What results would YOU want from a 
drug treatment when your rheumatoid arthritis 
is bad?’ and importance categories: ‘Not 
important’, ‘Important’ and ‘Very important’. 
Participants, working individually, rated the 
personal importance of each outcome. The 
number of cards to be placed in each category 
was neither specified nor limited. In discussion 
with the patient partner, with whom this process 
was trialled, it was decided that a second stage 
of ranking was required because of the potential 
large number of very important outcomes. 
Therefore, the outcomes in the ‘Very important’ 
pile were then re-ranked into ‘Very important’ 
and ‘Most important’ piles, again working indi-
vidually. Then, only the outcomes rated as 
‘Most important’ were retained for Round 2.
Round 2: Group consensus 
forming
This round was recorded and transcribed ver-
batim. In each group, individuals reported one 
‘Most important’ outcome at a time to the 
other participants and these were written by 
T.S. onto a group list, on a flipchart. After 
three or four circuits of the group, they were 
asked if there were additional outcomes that 
were extremely important that should be 
added. A group discussion was facilitated by 
T.S. to explore why patients had selected their 
priority outcomes. The face-to-face nature of 
the NGT was chosen to allow these experts to 
share experiences and opinions.
Round 3: Individual ranking of 
priority outcomes
Working individually, participants selected 
their top five most important treatment out-
comes from the group list in Round 2 and 
ranked them in order of importance. Practically, 
participants wrote down the top five outcomes 
and then wrote a number (1–5) next to each 
outcome to signify its ranking. It was decided 
to rank the top five outcomes rather than the 
whole group list, since, in consultation with the 
patient partner, it was decided that ranking a 
greater number would become difficult and 
possibly arbitrary.
After five groups were conducted, it was 
decided that a sufficient diversity of partici-
pants had taken part and a large number of 
selected priority outcomes was evident across 
the groups overall. The groups lasted approxi-
mately 1.5 hours.
Analyses
From Round 3 data, scores (1–5) were summed 
for each outcome selected across all partici-
pants. A percentage of the maximum possible 
score was then calculated for each outcome 
((score from Round 3 / 5 × number of partici-
pants) x 100). The qualitative data from Round 
2 were analysed using a Grounded Theory cod-
ing paradigm (Strauss & Corbin, 1998) for fac-
tors influencing patients’ prioritization of 
treatment outcomes. Coding levels 1, 2 and 3 
were used to identify open codes, group them 
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into axial codes and form categories through 
constant comparison. Data were managed using 
NVivo2 software. The patient partner (P.R.) 
reviewed the interpretation of data with T.S.
Results
Participants recruited
Five nominal groups with 26 RA patients were 
conducted (Table 1). Thirty-seven participants 
had agreed to take part, but 11 did not attend 
because of flares of inflammation (including 
two cases of hospitalization) and anticipated 
fatigue from work commitments. However, a 
diversity of participant characteristics was still 
achieved. Next, the quantitative results are pre-
sented briefly to provide context for the main 
focus of the article: the qualitative findings.
Quantitative results
Thirty-two outcomes (out of 63) were selected 
in the top five most important outcomes across 
all participants, indicating the diversity of pri-
orities for participants. The top five outcomes 
prioritized overall by the nominal groups were 
‘Less pain’ (43.8% of possible maximum 
Table 1. Profile of participants.
Study 
code










1A F 77 23 8.5 N N Y
1C F 46 31 5.0 N N Y
1E F 53 12 4.0 N N Y
1F F 62 12 7.5 Y N Y
1G F 35 2 8.0 N N N
1H F 67 12 8.0 Y N Y
2B M 70 21 0.0 N N N
2C M 46 19 4.0 N Y N
2E M 47 2 5.0 Y N N
3A F 61 12 4.5 N Y Y
3B F 75 22 5.0 N N Y
3C F 63 17 7.0 N N Y
3D F 66 11 3.0 N N Y
3E F 59 19 6.5 N N Y
3F F 61 36 4.0 N Y Y
3G F 59 7 4.0 N N Y
4C F 65 10 3.0 Y N N
4E F 62 9 1.0 N N N
4G F 61 8 2.0 N N N
5A F 56 9 10.0 Y N N
5B F 61 2 6.0 Y Y N
5C M 63 24 3.5 N N N
5D F 54 12 2.0 N N N
5E F 62 29 9.0 Y N N
5F F 79 4 8.0 N N N
5G M 29 10 6.0 Y N Y
Note: aPatient opinion of disease activity (10 = worst).
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priority score for outcome), ‘No more joint 
damage’ (40.8%), ‘Less fatigue’ (16.2%), ‘Doing 
everyday things’ (14.6%) and ‘More mobility’ 
(13.1%). Because of the diversity of outcomes 
selected as most important in Round 3, a cut-off 
score for establishing consensus was not used 
and it was decided to conduct a multi-centre 
postal survey to make the final selection 
(Sanderson et al., 2010b).
Qualitative findings
The qualitative data provided insight into why 
specific outcomes were prioritized over others. 
Four major categories of influences on prioriti-
zation were identified: disease impact; adapta-
tion to illness; external resources and stressors; 
and social expectations (Fig. 1). Together, these 
were encompassed by a fifth larger category: 
global impact. Each of these will now be 
described. Quotations have an identifier for the 
participant (digit identifies group) and the rank-
ing of the relevant outcome from Round 3 
where appropriate.
Global impact included the outcomes qual-
ity of life, normal life and feeling well. They 
were commonly prioritized in the top five 
because they encompassed a number of more 
specific treatment outcomes:
I chose it [quality of life] because it kind of cov-
ered everything. Things like less fatigue, less 
pain, being more able to work, being able to exer-
cise. (5G: Quality of life = 2nd)
I think if you feel well you feel capable of dealing 
with everything, you’ve got more sort of stamina 
and a sense of getting on with things. (1F: Feel 
well = 1st)
However, it was clear that the meaning of these 
global outcomes differs from person to person 
and it was necessary to determine the specific 
outcomes encompassed by such terms.
Disease impact is a large category that 
included symptoms of RA, avoiding irreversi-
ble joint damage and functional impairment. 
The severity of RA symptoms was a key factor 
in the selection of priority outcomes. Pain was a 
dominant factor (and the first priority of the 
groups overall), but other symptoms such as 
fatigue and joint weakness were also described:
‘Less pain’ because I just think some of the other 
things I’ve put, like enjoying life and feeling well, 
actually come from that. (4E: Less pain = 2nd)
You’re too tired. I very rarely go [out]. It’s got to 
be something really special, and then I rest in the 
day because you can’t go out at night. (3C: Less 
fatigue = 2nd)
There was surprise from some participants 
that pain was ‘so far down on the list’ (4G) of 
priorities. Reasons given were that medication 
can control pain and that people can learn to 
live with pain. Thus other outcomes, which are 














Global impact of RA
Figure 1. Factors influencing patient prioritization of treatment outcomes.
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The first thing I think of when I think of it [RA] 
is pain, and yet those other things are more 
important. It’s just surprising, that’s all. (4G: 
Less pain = 5th)
Once your drugs are working they can decrease 
the pain. (3D: Less pain = 4th)
You get used to living with pain. So long as I 
can get on and do other things despite the pain. 
(5D: Doing things I want = 3rd, Less pain not 
ranked)
Joint damage was ranked as the second pri-
ority by the groups overall. Partly, this was 
because participants perceived it as less treata-
ble, and the cause of the other symptoms:
An awful lot of treatment that you have stops the 
pain, but it doesn’t necessarily stop the damage to 
your joints. (1E: No more joint damage = 1st)
I might say ‘no more joint damage’ because I 
think everything else would flow from that. (5G: 
No more joint damage = 1st)
In addition, joint damage was prioritized 
because of the consequent functional disability, 
which could affect both everyday activities and 
valued activities, which give meaning and 
pleasure to people’s lives:
I think it’s the ultimate fear of losing [the use of] 
your hands. (1F: No more joint damage = 3rd)
I love housework and to not be able to do my 
housework would be the worst thing. (4G: No 
more joint damage = 1st, Doing everyday 
things = 2nd)
Similarly, independence and mobility were out-
comes prioritized because of their contribution 
to increasing functional disability:
I get, not ashamed, but embarrassed, because I 
actually live in a sheltered scheme for elderly 
people, and I got in because of the disability. 
Some of the neighbours in the house, they’re in 
their 80s and they’re fitter than I am. (5D: 
Maintain independence = 1st, in her 50s)
Problems I’ve seen starting in the feet and the feet 
affect everything, how you walk and everything. 
(3F: More mobility = 2nd)
Symptoms and impairment commonly 
affected participants’ emotional well-being. 
Although mood-related outcomes, such as 
‘Better mood’ and ‘Less depressed’ were not 
prioritized, the emotional influence on the 
choice of priority outcomes was clear:
I think you’re sometimes excluded from certain 
things, I’m told to go sit down and not be part of 
what’s going on and that’s very frustrating. (3E: 
Doing everyday things = 1st)
There’s times when there’s things I wanna do and 
I can’t, and I get quite irritable about that. (2B: 
Feel useful = 2nd)
A trade-off between different symptom- and 
impairment-related outcomes was commonly 
described in the process of prioritization. For 
example: ‘I put here “avoid surgery”, but “no 
more joint damage” covers that side, because if 
I don’t have it I wouldn’t need surgery, would 
I?’ (4C: No more joint damage = 1st)
The adaptation to illness category of influ-
ences included patients’ perceptions of both cog-
nitive and behavioural strategies. There was 
recognition of the role of attitude in managing RA 
and this appears to have influenced the process of 
prioritization by decreasing the importance of 
specific manifestations of the condition:
If you can be in control a bit more you’d have 
better quality of life. (5E: Quality of life = 1st, 
Less pain = 5th)
I’ve had it [RA], like, since I was 25, so I’ve had 
it 35 years. … I’ve always had to say to myself 
that I can do it, I can do it, no matter what. (3F: 
Normal life = 1st, Less pain = 5th)
Ability to self-manage symptoms was also an 
influence on prioritization of outcomes:
 at University of Bristol Library on January 6, 2012hpq.sagepub.comDownloaded from 
138 Journal of Health Phychology 17(1)
I chose that one next because I can’t do anything 
about the weakness in my wrists, but I can take 
something for the pain. (4G: Weakness in wrists = 
3rd, Less pain = 5th)
Trying to cope with a job is difficult. I couldn’t 
cope with it any longer and had to retire. So I put 
that as not important. (3C: Able to work not 
ranked)
Sometimes there were indications that pri-
orities had changed with increasing disease 
duration because of adaptation, knowledge 
about the condition or tolerance of symptoms or 
impairment:
Five years ago, not walking really did upset me 
… I mean, why I wasn’t walking … and couldn’t 
understand why I wasn’t. But now, you see, it’s 11 
years. (4C: No more joint damage = 1st, More 
mobility = 5th)
When I first got ill, I didn’t know much about 
the illness at all. … It’s just that over time I 
found ways to cope with it. (5G: No more joint 
damage = 1st, Coping not ranked)
Illness and treatment beliefs also played a part 
in how outcomes were prioritized:
Pain is more of a side-effect of the illness so it’s 
more important to me to try and combat the ill-
ness. (5G: No more joint damage = 1st, Less 
pain = 4th)
There’d be no point really because if it’s going to 
happen, it’s going to happen anyway, isn’t it? It’s 
really having the drugs to stop it from happening. 
(1F: Feel well = 1st, No more joint damage = 3rd)
Therefore, adaptation to the condition overall 
and tolerance of symptoms appears to affect the 
ordering of priority outcomes. These factors 
may result in outcomes such as pain becoming 
less of a priority as disease duration increases.
During discussion in the groups, it was evi-
dent that external resources and stressors were 
important contextual factors in deciding prior-
ity outcomes. The presence or absence of social 
support could have a large impact on how par-
ticipants managed their condition:
Some of us are on their own and they probably 
find things a bit more difficult. Sometimes I like to 
try and do something myself, just perhaps getting 
a bottle top off, and I just have to give up. (1A)
If I get a bad day he [husband] really moans. I’m 
sure he would rather me go to bed than sit cosily 
in a chair and look miserable. (4C)
Participants’ inability to work was a source 
of stress, and had implications for being able to 
afford alterations at home:
It might have stopped you going to work, your 
wage isn’t coming in, or whatever. (5B)
When I was really bad, I still had to carry on with 
the mortgage payments. (2C)
If you’ve got all the gadgets to help you cope and 
you’ve had all the alterations, you can still be hav-
ing it [RA], but you are coping quite well. (3E)
A couple of participants described the role 
of employers in supporting people with RA at 
work:
It [RA] does raise the point about awareness in 
the workplace, because most workplaces wouldn’t 
recognize it [RA]. (5B)
My manager noticed it before me, because I 
couldn’t get up the stairs very well and so he just 
came and tapped me on the shoulder one day. If I 
wanted anything picked up or run somewhere, he 
gave me a lad to do it. (4C)
The presence of co-morbidities is another 
issue that was not always considered by rheu-
matology health professionals, according to 
participants, and could be a source of further 
stress: ‘There are these things, what some peo-
ple call “complicating illnesses”. There is a 
possible impact because of not seeing much in 
one eye. Will I be able to carry on working to 
the extent that I am?’ (5D).
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Overall, participants suggested that external 
resources and stressors may modify the influ-
ence of the direct impact of the RA and there-
fore the prioritization of treatment outcomes. 
For example, social support may alleviate the 
challenge of coping with severe symptoms 
and allow the prioritization of non-bodily out-
comes, whereas stressors may make physi-
cally or psychologically managing symptoms 
more difficult.
Social expectations was another category 
that emerged in general conversation about 
important treatment outcomes. The perceived 
ability to fulfil social roles could also affect pri-
oritization of outcomes:
I found it frustrating, you know, being young and 
then having children. You can’t rough and tumble 
with the children … That was very frustrating as 
a parent. (5C: Less frustrated = 2nd)
If I’m in a meeting, you know you talk with your 
hands and all of a sudden you have to go ‘oooh’ 
because you’ve hurt yourself, instantly you’re 
turned from somebody who is in command of 
everything to somebody who’s hurt. (2C: Able to 
work = 1st)
Participants appreciated that at different 
ages and stages of life people with RA would 
value different outcomes. For example, 5G, 
who was in his 20s, was concerned about the 
ability to work, whereas 5C was retired and no 
longer expected to work: ‘I’m feeling sorry for 
myself, but you’ve got to think of the young 
ones, like [5G]. I had 24 years of good health, 
you know’ (5C).
Where expectations about appropriate roles 
were disrupted, people’s identities and social 
networks were negatively affected:
I’m not fanatical, but yes, I do like everything to 
be clean and tidy. But it’s important, you know. 
You’ve become a little bit diminished as a person 
if you can’t do those things. (4E)
I was told by the doctor to give it [work] up. 
You sort of lose friends and you lose the com-
pany. (3G)
Disruption of social expectations appeared 
to be mediated by the ability to cope and adapt 
to RA (Fig. 2). Where participants had accepted 
the impact of the RA in their lives or had posi-
tive role models for living with a long-term 
condition, social expectations appeared to have 
less influence: ‘I was diagnosed 30 years ago 
and my father had it, so although I was young 
I’d seen him still carrying on with his garden 
and I thought “If he can cope with it, so can I”’ 
(5E). It appears that social expectations may 
particularly influence the prioritization of work 
and domestic activity-related outcomes, but 
further research is required regarding the rela-
tionship between broad social influences and 
outcome prioritization.
Discussion
The qualitative data generated from the nomi-
nal groups with RA patients provide an insight 
into the influences on patients’ prioritization of 
treatment outcomes, and the diversity in priori-
ties between participants (the top priority, “Less 
pain”, achieved 43.8 per cent of the maximum 
possible score). Although the severity of symp-
toms and impairments appeared to be the main 
factor determining prioritization of treatment 
outcomes, patients took into consideration the 
effect of self-management and adaptation, the 
resources available to them, stressors additional 
to the RA and broader social expectations. The 
data illustrate how it is the personal impact of 
RA that affects prioritization.
The personal impact of functional disability 
in RA has previously been recognized. For 
example, the Personal Impact Health Assessment 
Questionnaire (PI HAQ) measures the personal 
importance of specific activities of daily living 
as well as the level of disability in each activity 
in order to calculate a personal impact of disa-
bility (Hewlett et al., 2002). Carr et al. (2003) 
suggested that the relative importance of out-
comes described in focus groups depended on 
the stage of disease and on specific situations, 
such as disease flare. This article reveals that 
adaptation, external resources and stressors, 
and social expectations also influence the 
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ranking of outcomes. This is important because 
studies have shown that response shift (a re-
conceptualization of health) may mask treat-
ment efficacy in clinical trials and should 
therefore be measured alongside the traditional 
PROs such as pain and disability (Ahmed et al., 
2004; Ring et al., 2005). The data also illustrate 
how the process of prioritization involved a 
complex series of judgements and comparisons 
by patients. Therefore, the patient-reported gen-
eral health and global disease activity visual 
analogue scales that are commonly used in RA 
trials (Kalyoncu et al., 2009) may capture what 
is most important to patients at the time of com-
pleting the scale (e.g. pain), rather than assess-
ing global variables.
The common prioritization of global out-
comes such as quality of life, feeling well and 
normal life to encompass other important spe-
cific outcomes had not been anticipated. 
Despite being a logical decision by the partici-
pant, the global outcomes are often too general 
in a clinical or research setting to be useful in 
establishing treatment outcome priorities to be 
assessed. In collaboration with the patient 
partner, we decided to separate the outcomes 
identified as global by the nominal group par-
ticipants for the presentation of the quantitative 
results and for the next phase of the research, a 
postal survey to make the final selection of pri-
ority outcomes (Sanderson et al., 2010b). 
Researchers considering the NGT should hesi-
tate about the inclusion of global items in rank-
ing exercises for this reason.
There were several benefits of using NGT 
with patients. First, personal views and priori-
ties could be clarified, and atypical responses 
could be discussed by the group to enhance 
understanding of others’ perspectives. Second, 
the patients’ decision-making process was made 
transparent by recording the group discussion 
as qualitative data. Third, patients reported 
being empowered by expressing their priorities, 
and symptoms and experiences were validated. 
For example, RA patients report that fatigue is a 
common symptom of RA, but is often ignored 
by health professionals (Hewlett et al., 2005). 
Forming a consensus in these groups that 
fatigue was a common priority reinforced their 
individual experience. Overall, the NGT was an 
effective and democratic method to use with 
patients and the majority of participants coped 
well with the large number of outcomes.
Collaboration with the patient partner was 
essential and improved both the practical facili-
tation of the groups and ranking methodology. 
Practical suggestions included supplying rub-
ber grips to make sorting the laminated out-
come cards easier for those with limited hand 
mobility, and holding the groups in the after-
noon to allow morning joint stiffness to sub-
side. Two stages of ranking in Round 1 were 
included after trialling the method with the 
patient partner, and this enabled patients to 
refine their priorities further.
The nominal groups enabled a preliminary 
prioritization of important treatment outcomes, 
which facilitated the subsequent postal survey 
where consensus was finalized. Where the NGT 
is the sole method for establishing consensus in 
a study, we recommended that a group list of 
five items (maximum) is constructed (Round 2) 
to avoid larger numbers of outcomes across all 
groups. In addition, it would be essential to 
determine a consensus level before the priority 
scores are calculated. In other NGT and Delphi 
studies, consensus levels have ranged from 51 
per cent to 75 per cent (Endacott et al., 1999; 
Loughlin and Moore, 1979). Setting a consen-
sus level is essentially an arbitrary decision, but 
would be aided by the inclusion of clinicians’ 
and patient partners’ opinions.
There were strengths and limitations specific 
to this study. Eleven participants dropped out at 
short notice, mainly due to a severe flare in their 
condition (although eight participants reporting 
flare did attend). This is to be expected during 
research with chronically ill people. Separating 
participants according to single or mixed gen-
der groups appeared to have no effect on treat-
ment outcome prioritization in the quantitative 
or qualitative data, but the numbers of men 
were small. However, having separate treat-
ment groups was a strength and a condition of 
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participation by one patient because she per-
ceived a risk of creating frustrations around 
access to the more expensive anti-TNF thera-
pies and raising expectations about potential 
improvement. The qualitative data indicated 
that patients’ priorities change over time, and 
future research could assess priorities longitudi-
nally to capture changes in important treatment 
outcomes as they occur.
In conclusion, the nominal groups not only 
facilitated the systematic prioritization of over 
60 treatment outcomes, but enabled the reasons 
for prioritization to be explored. The factors 
that influenced patients’ ranking of treatment 
outcomes were: direct impact of RA; adaptation 
to illness; external resources and stressors; and 
social expectations. The diversity of individu-
als’ top five priority outcomes appears to be due 
to variation of the personal impact of these 
influences on their lives. The NGT was an 
effective technique to use with patients and the 
collection of qualitative data provided valuable 
information for the extra resources required. 
User involvement in the design of the nominal 
groups facilitated data collection. The potential 
for increasing the use of nominal groups with 
patients as experts relies on the health care 
community valuing patients’ experience and 
knowledge.
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